Guerbet Vendor's profile

Guerbet to Exhibit Recently U.S. Approved Imaging Agents at 100 Year Anniversary of RSNADotarem® (gadoterate meglumine) Injection and Lipiodol® (ethiodized oil) Injection to both be presented at Guerbet booth; Guerbet to present five abstracts Princeton (NJ), Guerbet, a pioneer in the field...

Guerbet Receives FDA’s Drug Shortage Assistance Award Recognized for contributions to address a shortage of Ethiodol (ethiodized oil) injection Guerbet LLC, USA (September 29, 2014) Princeton (NJ), Guerbet, a pioneer in the field of contrast agents for medical imaging, has received a Dr...

FlowSens®: a new-generation solution in CT imaging
星期五, 2014年 三月 07日

  FlowSens®: a new-generation solution in CT imaging Presented for the first time at the European Congress of Radiology (ECR, Vienna, 7-10 March 2014), this unique, innovative solution enables Guerbet to broaden its range in the field of medical equipment and devices for diagnostic...

2014 first-half results
星期五, 2014年 八月 01日

   2014 first-half results›        Revenue at constant exchange rates : €206.8M ; +7.5%›        Current operating income : €19.8M ; 9.8% of reported sales  Solid growth on track with roadmap (€412M in re...

FDA Approves Lipiodol® (Ethiodized Oil) Injection for Imaging of Tumors in Adults with Known Hepatocellular Carcinoma (HCC) Princeton (NJ), Guerbet, a pioneer in the field of contrast agents for medical imaging announced that Lipiodol® was approved by the US Food and Drug Administration purs...

Contact Guerbet

Title *
Company / organisation *
Firstname *
Job title *
Lastname *
City *
E-mail *
Country *

All information that you supply is protected by our privacy policy.
In order to provide you with this free service, we may share your business information with companies whose content you choose to view on this website.
By submitting your information you agree to our Terms of Use. - See more at: IMAIOS privacy policy

To feature here :  Get in touch